JC
Jacob Changetharayil Benjamin
About Jacob Changetharayil Benjamin
Data last updated:
Jacob Changetharayil Benjamin is a Director at Merai Newage Private Limited (since 2023), Director at Mitsu Private Limited (since 2021) and Director at Micro Crispr Private Limited (since 2021), and holds 7 more current directorships. The companies operate in Information Technology, Agriculture and Life Sciences. The 4 current companies with reported revenue have a combined latest revenue of ₹150 Cr; the largest is Merai Newage Private Limited at ₹79.36 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Merai Newage Private Limited U62099GJ2023PTC146394 | Director | 21 Nov 2023 | 2023 | ₹79.36 Cr (FY 2025) | Active |
| Mitsu Private Limited U24231GJ1993PTC038905 | Director | 13 Dec 2021 | 1993 | ₹68.02 Cr (FY 2025) | Active |
 Micro Crispr Private Limited U33309GJ2021PTC124575 | Director | 02 Aug 2021 | 2021 | ₹3.08 Cr (FY 2025) | Active |
| Nuvo Labs Private Limited U62099GJ2023PTC143047 | Director | 18 Jul 2023 | 2023 | ₹43,000 (FY 2025) | Active |
| Micro Cell Therapies Private Limited U21009GJ2026PTC181509 | Director | 29 Jul 2026 | 2026 | Active | |
| Merai Accelerators Private Limited U62099GJ2024PTC150825 | Director | 22 Apr 2024 | 2024 | Active | |
| Nuvo Ai Private Limited U62099GJ2023PTC142003 | Director | 09 Jun 2023 | 2023 | Active | |
| Micro Synbio Private Limited U33100GJ2022PTC135201 | Director | 02 Sep 2022 | 2022 | Active |
Board colleagues of Jacob Changetharayil Benjamin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pramodbhai Shankerbhai Patel | 08054110 | Merai Newage Private Limited | Director |
| Nanubhai Premjibhai Bambharolia | 00089481 | Mitsu Private Limited | Director |
| Nikita Keyur Jajal | Mitsu Private Limited | Company Secretary | |
| Himmat Sunder Lal Lodha | 05211039 | Micro Crispr Private Limited , Nuvo Labs Private Limited and 6 more | Director |
| Yukti Ajitkumar Jain | Micro Crispr Private Limited | Company Secretary | |
| Anjum Gafulbhai Bilakhia | 00171014 | Micro Cell Therapies Private Limited | Individual Subscriber |
| Sunil Prakash Jain | 11858260 | Micro Cell Therapies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jacob Changetharayil Benjamin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jacob Changetharayil Benjamin
Jacob Changetharayil Benjamin currently holds 10 directorships: Merai Newage Private Limited (Director, since 21 Nov 2023, revenue ₹79.36 Cr (FY 2025)); Mitsu Private Limited (Director, since 13 Dec 2021, revenue ₹68.02 Cr (FY 2025)); Micro Crispr Private Limited (Director, since 02 Aug 2021, revenue ₹3.08 Cr (FY 2025)); Nuvo Labs Private Limited (Director, since 18 Jul 2023, revenue ₹43,000 (FY 2025)); Micro Cell Therapies Private Limited (Director, since 29 Jul 2026); and 5 more.
Jacob Changetharayil Benjamin was first appointed on 14 Jul 2021 as Director at Micro Medicines Private Limited. The most recent appointment on record is 29 Jul 2026 at Micro Cell Therapies Private Limited.
The 4 current companies of Jacob Changetharayil Benjamin that report revenue have a combined latest revenue of ₹150 Cr: Merai Newage Private Limited ₹79.36 Cr (FY 2025); Mitsu Private Limited ₹68.02 Cr (FY 2025); Micro Crispr Private Limited ₹3.08 Cr (FY 2025); Nuvo Labs Private Limited ₹43,000 (FY 2025).
The current boards of Jacob Changetharayil Benjamin's companies include Pramodbhai Shankerbhai Patel (Merai Newage Private Limited), Nanubhai Premjibhai Bambharolia (Mitsu Private Limited), Nikita Keyur Jajal (Mitsu Private Limited), Himmat Sunder Lal Lodha (Micro Crispr Private Limited), Yukti Ajitkumar Jain (Micro Crispr Private Limited), Anjum Gafulbhai Bilakhia (Micro Cell Therapies Private Limited), among others.